Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 414


Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.

Deng L, Wang D, de la Fuente C, Wang L, Li H, Lee CG, Donnelly R, Wade JD, Lambert P, Kashanchi F.

Virology. 2001 Oct 25;289(2):312-26.


Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT.

J Biol Chem. 1998 Sep 18;273(38):24898-905.


Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F.

Virology. 2000 Nov 25;277(2):278-95.


Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, Kashanchi F.

J Biol Chem. 2002 Feb 15;277(7):4973-80. Epub 2001 Dec 5.


HIV-1 tat transcriptional activity is regulated by acetylation.

Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C.

EMBO J. 1999 Nov 1;18(21):6106-18.


HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, Harrod R.

J Biol Chem. 2005 Mar 11;280(10):9390-9. Epub 2004 Dec 15.


Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.

Marcello A, Zoppé M, Giacca M.

IUBMB Life. 2001 Mar;51(3):175-81. Review.


Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.

Ott M, Schnölzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, Verdin E.

Curr Biol. 1999 Dec 16-30;9(24):1489-92.


Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.

Ott M, Dorr A, Hetzer-Egger C, Kaehlcke K, Schnolzer M, Henklein P, Cole P, Zhou MM, Verdin E.

Novartis Found Symp. 2004;259:182-93; discussion 193-6, 223-5. Review.


Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.

Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G.

J Biol Chem. 2003 Apr 4;278(14):12310-8. Epub 2002 Dec 24.


The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat.

Col E, Caron C, Seigneurin-Berny D, Gracia J, Favier A, Khochbin S.

J Biol Chem. 2001 Jul 27;276(30):28179-84. Epub 2001 May 30.


Steroid receptor coactivator-1 is a histone acetyltransferase.

Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW.

Nature. 1997 Sep 11;389(6647):194-8.


Acetylation of HIV-1 integrase by p300 regulates viral integration.

Cereseto A, Manganaro L, Gutierrez MI, Terreni M, Fittipaldi A, Lusic M, Marcello A, Giacca M.

EMBO J. 2005 Sep 7;24(17):3070-81. Epub 2005 Aug 11.


Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.

Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kundu TK.

J Biol Chem. 2004 Dec 3;279(49):51163-71. Epub 2004 Sep 20.


Kinetic mechanism of human histone acetyltransferase P/CAF.

Tanner KG, Langer MR, Denu JM.

Biochemistry. 2000 Oct 3;39(39):11961-9.


Small molecule modulators of histone acetyltransferase p300.

Balasubramanyam K, Swaminathan V, Ranganathan A, Kundu TK.

J Biol Chem. 2003 May 23;278(21):19134-40. Epub 2003 Mar 6.


Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry.

Dormeyer W, Ott M, Schnölzer M.

Methods. 2005 Aug;36(4):376-82.


Chromatin remodeling and modification during HIV-1 Tat-activated transcription.

Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD, Lambert P, Kumar A, Kashanchi F.

Curr HIV Res. 2003 Jul;1(3):343-62. Review.


Supplemental Content

Support Center